Clinical Trial Update: A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

The document reports a Phase 1/2 clinical trial of SHR-4610 injection in patients with advanced solid tumors, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• SHR-4610 (SHR-4610)

Snippet

Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd | Conditions: Solid Tumors | Phase 1, Phase 2 | Status: RECRUITING